Across drug-specific analyses, liraglutide, lixisenatide, semaglutide, and albiglutide generally showed no significant associations
Significant reductions in waist circumference, blood pressure, triglycerides, and fasting glucose were observed
All clinicians at Complete are trained to deliver shockwave
GSTM1 null individuals showed decreased excretion of SFN-GSH and SFN-CG suggesting that they may metabolize SFN less efficiently
The proposed direct vascular mechanisms, supported by preclinical and clinical data, include the following: Endothelial protection: GLP-1 receptor agonists promote nitric oxide production, vasodilation, and angiogenesis while inhibiting oxidative stress in vascular endothelial cells Plaque stabilization: Reduced matrix metalloproteinase activity prevents fibrous cap degradation